CalciMedica Inc. (NASDAQ: CALC)
$3.6600
-1.1400 ( -23.70% ) 184.8K
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
Market Data
Open
$3.6600
Previous close
$4.8000
Volume
184.8K
Market cap
$39.45M
Day range
$3.5300 - $4.0600
52 week range
$2.1400 - $8.3800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 54 | Oct 30, 2024 |
8-k | 8K-related | 15 | Oct 30, 2024 |
4 | Insider transactions | 1 | Sep 11, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |
4 | Insider transactions | 1 | Aug 28, 2024 |